SUMMARY An earlier preliminary paper is expanded. Women who had given birth to one or more infants with a neural tube defect were recruited into a trial of per:conceptional vitamin supplementation. Two hundred mothers attending five centres were fully supplemented (FS), 50 were partially supplemented (PS), and 300 were unsupplemented (US). Neural tube defect recurrences in the study pregnancies were 1 (O-5 %), in FS, none in PS, and 13 (4 %) in US mothers. The difference in outcome between FS and US mothers is significant. The most likely explanation is that supplementation has prevented some neural tube defects, but fu rther studies are needed.
the study pregnancies were 1 (O-5 %), in FS, none in PS, and 13 (4 %) in US mothers. The difference in outcome between FS and US mothers is significant. The most likely explanation is that supplementation has prevented some neural tube defects, but fu rther studies are needed.
It is nearly half a century since Hale' demonstrated an association between nutritional deficiency in a pregnant mammal and malformation in the offspring. His pioneer experiments established a causal relationship between vitamin A deficiency and a variety of birth defects, notably anophthalmia, in pigs. Subsequently Warkany and Nelson2 showed that malformations could be produced in rodents by the manipulation of maternal diet.
There is as yet no clear evidence to link nutritional deficiency with malformations in the human. However, there is considerable circumstantial evidence pointing to such an association. The widely observed social class gradient in the incidence of neural tube defects (NTD) suggests the possibility of a nutritional contribution to their causation. Significant social class differences in nutrient intake3 and in blood levels of folic acid, ascorbic acid, and riboflavin4 in early pregnancy have been reported. An association between abnormal folate metabolism at the end of pregnancy and NTD has been suggested5 but not confirmed.6 A relationship between poor diet and NTD recurrence, with possible benefit of dietary counselling, has recently been reported.7
In a prospective study of blood vitamin levels in the first trimester of pregnancy, mean blood levels of folate, ascorbic acid, and riboflavin were lower in a small group of mothers who later gave birth to infants with central nervous system malformations than in controls, the differences being significant for red cell folate and leucocyte ascorbic acid.4 To test the hypothesis that minor deficiencies of one or more vitamins may contribute to the causation of NTD, an intervention study has been carried out. Following our preliminary paper8 we now report the results of further analysis and follow-up. The figures in this paper do not match precisely those in the, earlier one. The main difference results from the inclusion here of partially supplemented mothers (defined below) and some additional unsupplemented mothers associated with them. Some minor adjustments result from more detailed scrutiny of our original data.
Patients and methods
This is a multicentre study. The participating centres and their related areas were: Leeds (Yorkshire region), Guy's Hospital, London (South-east England), Belfast (Northern Ireland), Manchester (North-west region), Chester (Cheshire).
We decided to offer periconceptional multivitamin supplementation to women who had already had at least one NTD infant,* and who therefore faced a risk of recurrence of about 5 %. Our original proposal for a double-blind placebo study was rejected by two research ethics committees (see below) and an alternative design was therefore adopted. This offered vitamin supplementation to all eligible women recruited to the study-that is, to any woman who had previously given birth to at least one NTD child, who was not pregnant, and who planned a further pregnancy at some time in the future. Such women were referred to the study from genetic counselling clinics, or by obstetricians, general practitioners, and health visitors. Supplementation was effected with Pregnavite Forte F (Bencard), 1 The proportion of supplemented to unsupplemented mothers in each centre is broadly comparable except for Belfast where there was an excess of unsupplemented.
Number of previous NTDs ( Table 2 ). The recurrence risk is known to be higher after 2 previous NTDs than after one. Among unsupplemented mothers, 270 had each had one previous NTD infant of whom 9 (3 %) had recurrences in the study pregnancy, compared with 4 (13%) of 30 among those who had had 2 previous NTDs. In subsequent tables mothers with 1 and 2 previous NTDs are treated separately. The proportions of FS and US mothers with 2 previous NTDs are comparable (9% and 10% respectively). Table 2 also gives the number of twin pairs, the number of unexamined spontaneous abortions, and hence the number of examined infants or fetuses for which presence or absence of NTD is known. Maternal age (Table 3 ). There is no consistent reported effect of maternal age on NTD incidence or recurrence, although the incidence has been higher among younger mothers in some studies, and among older mothers in others. The highest NTD recurrence rate in unsupplemented mothers was for the quinquennium 25-29 years, 9 (8%) of 116. The rate for mothers under 25 was 2 (2%) of 94, and for mothers 30 or more 2 (2%) of 90. The proportion of mothers aged 25-29 years was higher among the supplemented than the unsupplemented (FS 47 %, PS 40%, US 39 %) so the slight difference group Table 6 Outcome ofpregnancy in fully supplemented mothers with one previous NTD infant (n = 182: 4 twin pairs) by centre and social class Tables 6 and 7, and of US mothers in Tables 8 and 9 , according to number of previous NTDs, referral centre, and social class. Spontaneous abortions are separated into those for which the abortus was examined and those for which this was not possible. Among the offspring of US mothers there were 13 (4 %) NTDs in 305 infants/fetuses. Of these, 9 (3%) were born to 274 mothers with I previous NTD infant and 4 (13 %) to 31 mothers with 2 previous NTD infants. Comparable If spontaneous abortions not examined are excluded from the calculations, the recurrence rates for US infants were 3% after 1 NTD, 13% after 2 NTDs, 4 % overall; for FS infants recurrence rates were 0 * 6 %, 0 0 %, and 0 * 5 %. The lower recurrence rate in the FS compared with the US group is significant (P<0.01 one-tailed) by Fisher's exact method.
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In view of the theoretical possibility that vitamin supplementation, whether or not preventing NTDs, might harm the embryo/fetus, an attempt was made to examine all babies of FS mothers for birth defects. In addition, as many as possible were later tested for developmental progress, hearing, and vision. Follow-up data are not available for the children of mothers who attended Guy's Hospital. For the other centres, significant birth defects recorded and results of examination at age 5 months to 31 years are shown in Table 10 . Something other than vitamin supplementation has reduced the incidence of NTDs in the treated group. It is common experience that any kind of intervention tends to influence other things (for example, diet surveys may alter eating habits). Furthermore, the tablets, in addition to their declared iron, calcium, and vitamin content, contain 13 other ingredients (R J Ancil, 1981, personal communication). The possibility that the effect is indirect could be tested only by a placebo study.
Vitamin supplementation has prevented some NTDs. This remains the most straightforward explanation and it is consistent with other published work in this field. It cannot however, be regarded as proved.
There are important implications for further research and, if the hypothesis is confirmed, for health care policies An earlier proposal for a doubleblind placebo study was rejected by two research ethics committees, each for a different reason. These committees tend to record their decisions rather than their discussions and further retrospection seems pointless. However, the present position confirms the wisdom of our original intent because some important uncertainties remain. We regard placebo studies in high incidence areas as still desirable but ethically more difficult than before.
As regards the details of the supplementation regimen, the composition of the supplement and the duration of treatment deserve further study. Most of the earlier circumstantial evidence relates only to folic acid. Other studies4 also concern ascorbic acid and possibly riboflavin. It is desirable, and may be ethically acceptable, to try a more selective vitamin mix, or even folic acid alone. Regarding duration of treatment, data are accumulating from 'partially supplemented' mothers which may eventually answer this problem. In view of the practical difficulties of starting large-scale supplementation before conception it is important to continue studying mothers who begin supplements after conception. It is possible that a single dose taken on a specific day in the formation of the neural tube might be adequate15 but this would be very difficult to achieve in humans. (Indeed, if the hypothesis that NTDs result from breakdown of a previously closed neural tube is correct, the deadline for possible benefit may be later.)
Turning to health care policies, the results of this study, if confirmed, could influence the cost/benefit ratio of serum AFP screening, and would stress the need to extend antenatal care into the preconceptional period. We 
